SHELBY SCHWAB: Open Payments
NPI 1396315131 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,927 in 73 payments from 21 companies in 2025. Trend: 2023 $74 · 2024 $820 · 2025 $1,927
Food & beverage: $1,927
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $387 |
| Axsome Therapeutics, Inc. | 10 | $231 |
| Novo Nordisk Inc | 10 | $183 |
| Lilly USA, LLC | 4 | $160 |
| PFIZER INC. | 4 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $107 |
| Exact Sciences Corporation | 4 | $102 |
| Alkermes, Inc. | 3 | $78 |
| ABBVIE INC. | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
Products named: AIRSUPRA, Auvelity, NURTEC ODT, CAPLYTA, Cologuard Collection Kit, ARISTADA, REXULTI, Kerendia.
Industry payments across CO — which companies pay providers there.
